CVRx (CVRX) Operating Leases (2021 - 2026)
CVRx's quarterly Operating Leases came in at $544000.0 in Q1 2026, down 32.17% year-on-year from $802000.0 in Q1 2025, and down 14.73% quarter-over-quarter from $638000.0 in Q4 2025.
CVRx has reported Operating Leases for 6 years, with the latest figure at $544000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 32.17% year-over-year to $544000.0; the trailing twelve-month figure through Mar 2026 stood at $544000.0 (down 32.17% YoY), and the FY2025 full-year result was $638000.0, down 27.25% from the prior year.
- Operating Leases for Q1 2026 stood at $544000.0, down from $638000.0 in the prior quarter.
- The five-year high for Operating Leases was $1.2 million in Q4 2023, with the low at $59000.0 in Q1 2023.
- Average Operating Leases over 5 years is $670764.7, with a median of $802000.0 recorded in 2025.
- Year-over-year, Operating Leases tumbled 80.59% in 2023 and soared 1750.85% in 2024.
- Tracing CVRX's Operating Leases over 5 years: stood at $117000.0 in 2022, then jumped by 891.45% to $1.2 million in 2023, then fell by 24.4% to $877000.0 in 2024, then fell by 27.25% to $638000.0 in 2025, then declined by 14.73% to $544000.0 in 2026.
- The last three Operating Leases figures came in at $544000.0 (Q1 2026), $638000.0 (Q4 2025), and $730000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 544,000.00 |
| Dec 31, 2025 | 638,000.00 |
| Sep 30, 2025 | 730,000.00 |
| Jun 30, 2025 | 819,000.00 |
| Mar 31, 2025 | 802,000.00 |
| Dec 31, 2024 | 877,000.00 |
| Sep 30, 2024 | 951,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 916,000.00 |
| Jun 30, 2023 | 946,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Dec 31, 2022 | 117,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 250,000.00 |
| Mar 31, 2022 | 304,000.00 |
| Mar 31, 2021 | 512,000.00 |